The outlook of companies tied to the drug's legacy presents a complex investment landscape. While the initial surge generated substantial gains, generic alternatives have significantly diminished revenue. https://push2bookmark.com/story21808571/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-speculative-investment